Site icon

Using Graph Technology to Leverage ChatGPT-Like Tools

Using Graph Technology to Leverage ChatGPT-Like Tools

Image | AdobeStock.com

Neo4j’s Alexander Jarasch explains how to get the best from ChatGPT-like tools, while safeguarding intellectual property

ChatGPT has delivered a natural language understanding (NLU) interface to Artificial Intelligence (AI) while highlighting challenges facing life science sector users of AI. These include how to elicit the answers needed from AI—and whether to trust the answers it provides.

Generative AI works as a way to present the answers it derives from a Large Language Model (LLM). With programs like ChatGPT, whatever anyone has typed in to the internet has been ingested into its LLM and a subset is produced in answer to questions. If you’re working in drug discovery, it would be great to benefit from what competitors are working on. But if you put your team’s ideas online, they potentially become available to everyone else.

Using ChatGPT-like tools for serious data gathering should be approached with caution. Yet, generative AI presents a highly useful tool for general-purpose domain acquisition at the start of a project. The other main challenge in working with generative AI is how to derive value from integrating datasets with it.

Keep high-value data exploration in-house

It makes sense to keep potentially high-value data exploration in-house. By creating your own LLM based on your team’s results, field trials, or both, and supplementing it with publicly available scientific or medical database information, you can develop a robust, proprietary LLM. You could then use ChatGPT to analyze this private LLM while ensuring your organization’s intellectual property (IP) is safeguarded.

In addition, ChatGPT may not provide the depth of answers or the level of accuracy required from an unstructured heap of data. While it is possible to integrate PubMed’s 30 million peer-reviewed articles, the data quality is not guaranteed. Even in peer-reviewed articles, errors or differences in scientific interpretation may lead to inaccurate information.

Enter knowledge graphs

In order to create a knowledge base that is useful for research purposes, it is essential to structure and organize the data in a manner that allows patterns and connections to be identified easily for ChatGPT to use. One approach that is becoming increasingly popular is the use of a knowledge graph, which can transform your private LLM into a powerful research engine.

Knowledge graphs, as defined by the Turing Institute, “organize data from multiple sources, capture information about entities of interest in a given domain or task (such as people, places, or events), and create connections between them.” A graph-based knowledge graph of a specific, targeted piece of biomedical domain, can support a lot of valuable data analysis work.

During research on COVID-19, looking at disease-connected genes by connecting the data in this way, it became possible to quickly query and analyze relationships. It was then possible to analyze these relationships between the modules or sub-graphs of the genes in the virus but also see the connections between genes and corresponding proteins. This allowed researchers to identify a number of genes and affected metabolic pathways and understand more about what was going on in this area of disease research.

In these cases, the ability to use a natural language interface instead of writing code means the research team could more easily navigate complex data structures and identify specific patterns or relationships of interest.

BioCypher breakthrough

Researchers made an important breakthrough with the creation of BioCypher, a FAIR (findable, accessible, interoperable, reusable) framework that builds biomedical knowledge graphs while preserving all the links back to the source data.

The BioCypher team took a large corpus of medical research papers, built a large language model around them, and then derived a knowledge graph from the model. This approach allowed researchers to more effectively interrogate and work with that mass of previously unstructured, but now very well-organized and well-structured, data. And having the data in a knowledge graph means it is transparent and its answers enable better deliberation.

This approach can be replicated effectively, using an LLM to do the natural language ingestion heavy lifting. This would allow life science professionals to create a knowledge graph that will help make the most sense of the data.

Accessible to non-computer scientists

Using a natural language interface approach to translate questions or statements into Cypher code to then query in-house data store is infinitely superior for research purposes than imprecise ChatGPT answers. The NLU approach can make it much more accessible for non-computer scientists to work in a database and ask meaningful questions. Typically, researchers do not ordinarily want to interact with database querying layer and do not feel comfortable if you use technical terms like “Cypher” or “Python.”

NLU interfaces enable real-life interrogation of patient data, for example, whether Type 2 diabetic patients in a trial have a secondary clinical condition, such as liver cancer. This type of query is precisely what life science researchers need to achieve as they seek to ask meaningful questions and obtain useful answers from their clinical trials.

Using ChatGPT-like systems to support converting natural language into data queries is key to getting valuable answers from complex data systems. It is clear that NLU, in conjunction with a knowledge graph, is set to unlock the next generation of health research.

About the author

Dr. Alexander Jarasch is Technical Consultant for Pharma and Life Sciences at graph database and analytics leader Neo4j. He was formerly Head of Data and Knowledge Management for the German Center for Diabetes Research (Deutsches Zentrum für Diabetesforschung, DZD) where he helped use graph data science to meet its target of developing novel strategies for successful, personalized detection, prevention and treatment of diabetes and its complications via an innovative, integrative research approach.

Exit mobile version